diaendoСахарный диабетDiabetes mellitus2072-03512072-0378Endocrinology research centre10.14341/2072-0351-5811diaendo-5811Research ArticleСтатьиArticlesВзаимосвязь ингибитора активатора плазминогена и свободных жирных кислот с инсулинорезистентностью у больных инфарктом миокардаRole of plasminogen activator inhibitor and free fatty acids in diagnosis of insulin resistance in patients with myocardial infarctionГруздеваОльга ВикторовнаGruzdevaOlga Viktorovna-БарбарашОльга ЛеонидовнаBarbarashOlga Leonidovna-АкбашеваОльга ЕвгеньевнаAkbashevaOlga Evgen'evna-ФедороваТатьяна СергеевнаFedorovaTatiana Sergeevna-ПаличеваЕлена ИвановнаPalichevaElena Ivanovna-КашталапVasiliy ВасильевичKashtalapVasil'evich-ДылеваЮлия АлександровнаDylevaYulia Alexandrovna-СилоноваАнна АлександровнаSilonovaAnna Alexandrovna-СионинаЕкатерина ВладимировнаSioninaEkaterina Vladimirovna-УчасоваЕвгения ГеннадьевнаUchasovaEvgenia Gennad'evna-НИИ Комплексных проблем сердечно-сосудистых заболеваний, КемеровоResearch Institute of complex problems of cardiovascular disease RAMS, KemerovoНИИ Комплексных проблем сердечно-сосудистых заболеваний, Кемерово; ГБОУ Кемеровская государственная медицинская академия, КемеровоResearch Institute of complex problems of cardiovascular disease RAMS, Kemerovo; Kemerovskaya State Medical Academy, KemerovoГБОУ Сибирский государственный медицинский университет, ТомскSiberian State Medical University, TomskГБОУ Кемеровская государственная медицинская академия, КемеровоKemerovskaya State Medical Academy, Kemerovo201115122011144№4 (2011)1823Copyright © Груздева О.В., Барбараш О.Л., Акбашева О.Е., Федорова Т.С., Паличева Е.И., Кашталап V.В., Дылева Ю.А., Силонова А.А., Сионина Е.В., Учасова Е.Г., 20112011Груздева О.В., Барбараш О.Л., Акбашева О.Е., Федорова Т.С., Паличева Е.И., Кашталап V.В., Дылева Ю.А., Силонова А.А., Сионина Е.В., Учасова Е.Г.Gruzdeva O.V., Barbarash O.L., Akbasheva O.E., Fedorova T.S., Palicheva E.I., Кашталап V.В., Dyleva Y.A., Silonova A.A., Sionina E.V., Uchasova E.G.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.dia-endojournals.ru/jour/article/view/5811сахарный диабет 2 типаинфаркт миокардаинсулинорезистентностьсвободные жирные кислотыингибитор ак- тиватора плазминогенаtype 2 diabetes mellitusmyocardial infarctioninsulin resistancefree fatty acidsplasminogen activator inhibitor type-1ReferencesCollet J.P., Montalescot G., Vicaut E. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality // Circulation. - 2003. - Vol. 108. - P. 391-394.Collet J.P., Montalescot G., Vicaut E. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality // Circulation. - 2003. - Vol. 108. - P. 391-394.Ishihara M., Kojima S., Sakamoto T. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era // J. Am. Heart. - 2005. - Vol. 150. - P. 814-820.Ishihara M., Kojima S., Sakamoto T. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era // J. Am. Heart. - 2005. - Vol. 150. - P. 814-820.Alessi M., Juhan-Vague I. PAI-1 and the Metabolic Syndrome // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2006. - Vol. 26. - P. 2200-2207.Alessi M., Juhan-Vague I. PAI-1 and the Metabolic Syndrome // Arteriosclerosis, Thrombosis, and Vascular Biology. - 2006. - Vol. 26. - P. 2200-2207.Lopez-Alemany R., Redondo J. M., Nagamine Y., Munoz-Canoves P. Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with avb3 integrin for vitronectin binding // J. Eur. Biochem. - 2003. - Vol. 270. - P. 814-821.Lopez-Alemany R., Redondo J. M., Nagamine Y., Munoz-Canoves P. Plasminogen activator inhibitor type-1 inhibits insulin signaling by competing with avb3 integrin for vitronectin binding // J. Eur. Biochem. - 2003. - Vol. 270. - P. 814-821.Campbell I.W. The role of metformin and pioglitazone in early combination treatment of type 2 diabetes mellitus // Brit. J. of Diabetes & Vasc. Dis. - 2006. - Vol. 6. - P. 207-215.Campbell I.W. The role of metformin and pioglitazone in early combination treatment of type 2 diabetes mellitus // Brit. J. of Diabetes & Vasc. Dis. - 2006. - Vol. 6. - P. 207-215.Cefalu W.T. Insulin resistance: cellular and clinical concepts // Exp. Biol. Med. - 2001. - Vol. 226. - P. 13-26.Cefalu W.T. Insulin resistance: cellular and clinical concepts // Exp. Biol. Med. - 2001. - Vol. 226. - P. 13-26.Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies // B.M.J. - 2006. - Vol. 332. - P. 73-78.Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies // B.M.J. - 2006. - Vol. 332. - P. 73-78.Leclercq I.A., Da Silva Morais A., Schroyen B., Van Hul N., Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences // J. Hepatol. - 2007. - Vol. 47. - № 1. - P. 142-156.Leclercq I.A., Da Silva Morais A., Schroyen B., Van Hul N., Geerts A. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences // J. Hepatol. - 2007. - Vol. 47. - № 1. - P. 142-156.Lopaschuk G.D., Ussher J.R., Folmes C.D.L., Jaswal J.S., Stanley W.C. Myocardial Fatty Acid Metabolism in Health and Disease // Physiol. Rev. - 2010. - Vol. 90. - P. 207-258.Lopaschuk G.D., Ussher J.R., Folmes C.D.L., Jaswal J.S., Stanley W.C. Myocardial Fatty Acid Metabolism in Health and Disease // Physiol. Rev. - 2010. - Vol. 90. - P. 207-258.Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.L. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans // J. Clin. Endocrinol. Metab. - 2000. - Vol. 85. - P. 2402-2410.Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., Quon M.L. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans // J. Clin. Endocrinol. Metab. - 2000. - Vol. 85. - P. 2402-2410.Juhan-Vague I., Morange P.E., Frere C., Aillaud M.F., Alessi M.C., Hawe E., Boquist S., Tornvall P., Yudkin J.S., Tremoli L., Margaglione M., Di Minno G., Hamsten A., Humphries S.E. The Plasminogen Activator Inhibitor-1 -675 4G/5G genotype influences the risk of Myocardial Infarction associated with elevated plasma proinsulin/insulin levels in men from Europe // J. Thromb. Haemost. - 2003. - Vol. 1. - P. 2322-2329.Juhan-Vague I., Morange P.E., Frere C., Aillaud M.F., Alessi M.C., Hawe E., Boquist S., Tornvall P., Yudkin J.S., Tremoli L., Margaglione M., Di Minno G., Hamsten A., Humphries S.E. The Plasminogen Activator Inhibitor-1 -675 4G/5G genotype influences the risk of Myocardial Infarction associated with elevated plasma proinsulin/insulin levels in men from Europe // J. Thromb. Haemost. - 2003. - Vol. 1. - P. 2322-2329.Liang X., Kanjanabuch T., Mao S.L., Hao Chuan-Ming, Tang Yi-Wei, Declerck P.J., Hasty A.H., Wasserman D.H., Fogo A.B., Ma Li-Jun Plasminogen activator inhibitor-1 modulates adipocyte differentiation // J. Physiol. Endocrinol. Metab. - 2006. - Vol. 290. - P. 10-113.Liang X., Kanjanabuch T., Mao S.L., Hao Chuan-Ming, Tang Yi-Wei, Declerck P.J., Hasty A.H., Wasserman D.H., Fogo A.B., Ma Li-Jun Plasminogen activator inhibitor-1 modulates adipocyte differentiation // J. Physiol. Endocrinol. Metab. - 2006. - Vol. 290. - P. 10-113.
The authors declare that there are no conflicts of interest present.